|
ABBV
|
Healthcare |
Wolfe ResearchB |
Upgrade
|
Peer Perform
→
Outperform
|
$300
|
$439.3B
|
$248.76
|
+1.7%
|
+0.8%
|
-0.5%
|
+0.3%
|
+3.4%
|
+2.7%
|
|
ABT
|
Healthcare |
Wolfe ResearchB |
Upgrade
|
Peer Perform
→
Outperform
|
$130
|
$191.9B
|
$110.91
|
+1.4%
|
+0.3%
|
-0.0%
|
-0.8%
|
+2.1%
|
+1.6%
|
|
CRM
|
Technology |
JP Morgan |
Reiterates
|
Overweight
|
$250
|
$158.3B
|
$193.32
|
+1.8%
|
+4.2%
|
-2.6%
|
-2.7%
|
+2.7%
|
+5.1%
|
|
CRM
|
Technology |
Monness Crespi & Hardt |
Reiterates
|
Buy
|
$222
|
$158.3B
|
$193.32
|
+1.8%
|
+4.2%
|
-2.6%
|
-2.7%
|
+2.7%
|
+5.1%
|
|
SYK
|
Healthcare |
Wolfe Research |
Downgrade
|
Outperform
→
Peer Perform
|
—
|
$133.1B
|
$347.21
|
-0.6%
|
-1.8%
|
-0.6%
|
-2.2%
|
-0.1%
|
+2.6%
|
|
CCEP
|
Consumer Defensive |
UBS |
Downgrade
|
Buy
→
Neutral
|
$107
|
$47.5B
|
$107.08
|
-0.2%
|
+0.4%
|
+0.1%
|
-1.9%
|
+1.8%
|
-0.8%
|
|
KDP
|
Consumer Defensive |
HSBC Securities |
Upgrade
|
Hold
→
Buy
|
$40
|
$40.2B
|
$29.56
|
+1.7%
|
+5.3%
|
+1.0%
|
-3.7%
|
+1.7%
|
+0.9%
|
|
ALC
|
Healthcare |
BNP Paribas Exane |
Downgrade
|
Outperform
→
Neutral
|
$79
|
$35.9B
|
$73.58
|
+0.4%
|
-0.1%
|
+1.0%
|
-2.4%
|
+1.5%
|
+1.0%
|
|
BIIB
|
Healthcare |
Wolfe ResearchB |
Upgrade
|
Peer Perform
→
Outperform
|
$300
|
$30.9B
|
$208.87
|
+2.0%
|
+0.9%
|
-0.4%
|
-0.3%
|
+1.6%
|
+4.2%
|
|
WSM
|
Consumer Cyclical |
Telsey Advisory Group |
Reiterates
|
Outperform
|
$255
|
$28.9B
|
$245.15
|
+1.5%
|
-1.1%
|
-0.4%
|
-0.5%
|
+0.4%
|
+0.4%
|
|
MTSI
|
Technology |
The Benchmark Company |
Reiterates
|
Buy
|
$375
|
$23.7B
|
$310.75
|
-0.2%
|
-1.2%
|
+3.1%
|
+3.5%
|
-10.6%
|
-7.8%
|
|
AKAM
|
Technology |
JP MorganA |
Upgrade
|
Underweight
→
Neutral
|
$158
|
$17.9B
|
$122.78
|
+1.7%
|
+2.0%
|
-0.2%
|
-1.6%
|
-6.3%
|
-2.0%
|
|
KEP
|
Utilities |
Nomura |
Downgrade
|
Buy
→
Neutral
|
—
|
$14.8B
|
$11.88
|
-3.0%
|
-3.1%
|
+2.3%
|
+0.3%
|
-4.5%
|
-0.9%
|
|
FIVE
|
Consumer Cyclical |
JefferiesA+ |
Upgrade
|
Hold
→
Buy
|
$350
|
$13.2B
|
$238.15
|
+4.4%
|
+1.5%
|
+1.2%
|
-2.4%
|
-0.0%
|
+1.5%
|
|
TME
|
Communication Services |
Nomura |
Downgrade
|
Buy
→
Neutral
|
$10
|
$13.0B
|
$8.46
|
-0.7%
|
+2.4%
|
+2.1%
|
+0.3%
|
-0.9%
|
+2.6%
|
|
TECH
|
Healthcare |
Wells Fargo |
Downgrade
|
Overweight
→
Equal Weight
|
$73
|
$11.3B
|
$72.23
|
-0.0%
|
-0.1%
|
+0.3%
|
-0.0%
|
-0.2%
|
+0.4%
|
|
CAVA
|
Consumer Cyclical |
Northcoast |
Upgrade
|
Sell
→
Neutral
|
—
|
$8.1B
|
$69.47
|
+1.8%
|
+3.9%
|
+3.1%
|
-4.6%
|
-3.9%
|
+4.9%
|
|
ALGM
|
Technology |
The Benchmark Company |
Initiates
|
Buy
|
$60
|
$7.9B
|
$42.47
|
+0.7%
|
+3.9%
|
+0.6%
|
-0.3%
|
-11.0%
|
-2.6%
|
|
SM
|
Energy |
Wells FargoB |
Upgrade
|
Equal Weight
→
Overweight
|
$47
|
$7.8B
|
$32.42
|
+0.0%
|
+0.0%
|
+4.1%
|
+5.1%
|
+0.0%
|
+1.8%
|
|
SBSW
|
Basic Materials |
CitigroupC |
Upgrade
|
Neutral
→
Buy
|
$14
|
$7.6B
|
$10.71
|
-1.5%
|
-2.1%
|
+2.8%
|
+1.9%
|
-3.7%
|
+9.8%
|